维普期刊资源整合服务平台（V6.5）

28篇 您的检索式：作者名="Fleseriu"

选中清除导出查看参考文献查看引证文献引用追踪共2页首页上一页第1页下一页末页 /2 跳转

	题名	作者	年代	出处	被引量
1	Relative adrenal insufficiency 显示文摘	Loriaux DL Fleseriu M	2009	Curr Opin Endocrinol Diabetes Obes2009，16，5：	1
2	Advances in the pharmacotherapy of patients with acromegaly显示文摘	FLESERIU M	2014	Discov Med2014，17，：	1
3	Medical management of Cushing's disease:what is the future 显示文摘	Fleseriu M Petersenn S	2012	Pituitary2012，15，3：	1
4	Mifepristone, a glueoeortieoid receptor antagonist, produces clinical and metabolic benefits in patients with Cushing's syndrome 显示文摘	Fleseriu M Biller BM Findling JW	2012	J Clin Endoerinol Metab2012，97，6：	1
5	'Relative'adrenal insufficiency in critical illness显示文摘	Fleseriu M Loriaux DL	2009	Endocr Pract2009，15，6：	1
6	A new therapeutic approach in the medical treatment of Cushing’s syndrome:glucocorticoid receptor blockade with mifepristone显示文摘	FLESERIU M MOLITCH M E GROSS C	2013	Endocr Pract2013，19，2：	1
7	Relative adrenal insufficiency显示文摘	Loriaux DL Fleseriu M	2009	Curr Opin Endocrinol Diabetes Obes2009，16，5：	1
8	Relative adrenal in- sufficiency显示文摘	Loriaux DL Fleseriu M	2009	Curr Opin Endocrinol Diabetes Obes2009，16，39：	1
9	'Relative' adrenal insufficiency in critical illness显示文摘	Fleseriu M Loriaux DL	2009	Endocr Pract2009，20，：	1
10	Treatment options for Cushing disease after unsuccessful transsphenoidal surgery 显示文摘	Liu JK Fleseriu M Delashaw JB Jr	2007	Neurosurg Focus2007，23，3：	1
11	Anti-CTLA-4 antibody therapy associated autoimmune hypophysitis: serious immune related adverse events across a spectrum of cancer subtypes显示文摘	Troy Dillard Chris G. Yedinak Joshi Alumkal Maria Fleseriu	2010	Pituitary2010，，1：	1
12	Fracture risk in adult patientstreated with growth hormone replacement therapy for growth hor-mone deficiency : a prospective observational cohort study 显示文摘	Mo D Fleseriu M Qi R	2015	Lancet Diabetes Endocrinol2015，3，5：	1
13	Challenges and pitfalls in the diagnosis of hyperprolactinemia 显示文摘	Vilar L Fleseriu M Bronstein MD	2014	Arq Bras Endocrinol Metabol2014，58，1：	1
14	Mifepristone, a glueocorticoid receptor antagonist, produces clinical and metabolic benefits in patients with cushing's syndrome 显示文摘	Fleseriu M Biller BM Findling JW	2012	JClin Endocrinol Metab2012，97，：	1
15	Relative adrenal insufficiency显示文摘	LORIAUX D L FLESERIU M	2009	Curr Opin Endocrinol Diabetes Obes2009，16，5：	1
16	Mifepris- tone, a glucocorticoid receptor antagonist, produces clin- ical and metabolic benefits in patients with Cushing's syndrome显示文摘	Fleseriu M Biller BMK Findling JW	2012	The Journal of Clinical Endocrinology & Metabolism2012，97，6：	1
17	The role of combination medical therapy in aeromegaly: hope for the nonresponsive patient 显示文摘	Fleseriu M	2013	Curr Opin Endocrinol Diabetes Obes2013，20，4：	1
18	Fracture risk in adult patients trea-ted with growth hormone replacement therapy for growth hormonedeficiency : a prospective observational cohort study 显示文摘	Mo D Fleseriu M Qi R	2015	LancetDiabetes Endocrinol2015，3，5：	1
19	Treatment options for Cushing disease after unsuccessful transsphenoidal surgery 显示文摘	Liu JK Fleseriu M Delashaw JB Jr	2007	Neurosurg Focus2007，23，3：	1
20	Mifepristone,a glucocorticoid receptor antagonist,produces clinical and metabolic benefits in patients with Cushing's syndrome显示文摘	Fleseriu M Biller BM Findling JW	2012	J Clin Endocrinol Metab2012，97，6：	1

返回顶部每页显示：

共2页首页上一页第1页下一页末页 /2 跳转

互联网出版许可证新出网证(渝)字10号全国400电话 - 免长途话费

用户提示